MUSIANI, Piero
 Distribuzione geografica
Continente #
NA - Nord America 6.725
EU - Europa 6.142
AS - Asia 3.279
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 10
SA - Sud America 4
AF - Africa 2
Totale 16.181
Nazione #
US - Stati Uniti d'America 6.668
UA - Ucraina 1.444
CN - Cina 1.374
IE - Irlanda 1.030
TR - Turchia 1.023
GB - Regno Unito 980
SE - Svezia 757
FR - Francia 644
SG - Singapore 603
DE - Germania 452
IT - Italia 312
FI - Finlandia 270
IN - India 223
RU - Federazione Russa 161
CA - Canada 48
CZ - Repubblica Ceca 30
BE - Belgio 28
VN - Vietnam 28
EU - Europa 19
GR - Grecia 18
IL - Israele 14
MX - Messico 8
AU - Australia 6
IR - Iran 6
ES - Italia 5
HK - Hong Kong 4
NZ - Nuova Zelanda 4
PK - Pakistan 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
JP - Giappone 1
NL - Olanda 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
Totale 16.181
Città #
Jacksonville 1.443
Chandler 1.249
Dublin 1.025
Southend 818
Izmir 522
Singapore 504
Princeton 492
Dearborn 421
Nanjing 421
Wilmington 346
Cambridge 257
Beijing 218
Ann Arbor 180
Ashburn 157
Nanchang 142
Boardman 139
Woodbridge 130
New York 116
Santa Clara 114
Grevenbroich 99
Altamura 94
Shenyang 71
Hebei 67
Tianjin 62
Houston 61
Chieti 58
Jiaxing 55
Kunming 51
Jinan 41
Norwalk 41
Hangzhou 39
Orange 39
Changsha 37
San Mateo 35
Augusta 32
Brno 30
Helsinki 29
Brussels 26
Dong Ket 26
Hefei 25
Toronto 25
Grafing 24
Guangzhou 22
Los Angeles 21
Washington 19
Andover 18
Ningbo 18
Auburn Hills 17
Chicago 17
Leawood 17
Milan 16
Ottawa 15
London 14
Lanzhou 13
Changchun 11
Taizhou 11
Zhengzhou 11
Falls Church 10
Düsseldorf 9
Rome 9
Mexico City 8
Seattle 8
Simi Valley 8
Lanciano 7
Vasto 6
Walnut 6
Frankfurt am Main 5
Fuzhou 5
Haikou 5
Sydney 5
Tappahannock 5
Baotou 4
Ferrara 4
Ardabil 3
Chongqing 3
Jülich 3
Kocaeli 3
Monmouth Junction 3
Mumbai 3
Redwood City 3
San Donà di Piave 3
Shanghai 3
Shaoxing 3
Trumbull 3
Arcene 2
Auckland 2
Bangalore 2
Bari 2
Cedar Knolls 2
Curtarolo 2
Desio 2
Harbin 2
Hong Kong 2
Layyah 2
Montesilvano Marina 2
Pescara 2
Porto San Giorgio 2
Qingdao 2
Quzhou 2
Redmond 2
Totale 10.170
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 197
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 177
Role of GM-CSF in cryptogenic organizing pneumonia 131
Ruolo della IL-1 nella regolazione della produzione del TGFbeta1 e della IL-8 nei tumori del polmone "non-small cell". 122
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 117
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. 107
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 106
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 101
TGF-beta-1 and IL-8 in human long cancer cell lines and primary tumors: constitutive production and modulation by IL-1 100
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 99
Transforming growth factor beta1, interleukin-8 and interleukin-1 in human non-small cell lung tumor cell lines and primary tumors. 99
T3 expression by human thymocytes in culture. 96
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 93
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 92
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 92
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 91
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 91
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 90
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 90
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 89
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 88
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 88
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 88
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 87
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 86
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 86
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 85
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 85
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 84
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 84
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 84
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 84
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 84
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 83
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 83
Carcinomi polmonari umani: produzione di TGFbeta1 82
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 82
Proliferative capabilities of T3-positive thymocytes. 82
Analysis of IL-2-receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer. 81
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 81
Polymorphonuclear Leukocyte Apoptosis is Inhibited by Platelet-released mediators, Role of TGFbeta-1 81
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 81
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 81
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 81
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 81
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 81
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 80
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 80
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 80
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 79
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 79
IL-10 potentiates the effect of dexamethasone in inhibiting the proliferation of resting, activated and "corticoresistant" human T cells 79
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 78
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 78
Neutrophils in anti-cancer immunological strategies: old players in new games 77
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 77
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 77
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 76
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 76
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 76
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 76
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 76
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. 76
Inactivation of the IL-6 gene prevents development of multricentric Castleman's disease in C/EBP beta-deficient mice 75
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 75
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 75
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 75
Echinococcus granulosus: specific quantification of the two most immunoreactive antigens in hydatid fluids. 75
Alpha-l-antitrypsin deficiency and human pathology. 75
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 74
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 74
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 74
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 74
5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory 73
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 73
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. 73
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 73
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 73
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 73
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 72
THE ROLE OF ARACHIDONIC ACID METABOLITE PGE2 ON T CELL PROLIFERATIVE RESPONSE. 72
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 72
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 72
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 72
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. 72
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 72
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 72
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 72
Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells. 72
Immunological prevention of a multigene cancer syndrome. 71
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 71
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 71
Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation 71
Echinococcus granulosus: preparation of monosepcific antisera against antigens in sheep hydatid fluid. 71
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. 71
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. 70
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 70
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 70
Neutrophils in the antitumoral immune response 70
Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis. 70
Totale 8.353
Categoria #
all - tutte 54.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.933 0 0 1 177 183 323 416 351 34 123 298 27
2020/20211.618 261 5 246 9 221 340 10 6 135 253 44 88
2021/2022926 18 12 7 122 142 32 33 82 65 30 121 262
2022/20233.423 294 297 164 446 376 773 204 260 446 38 72 53
2023/20241.387 136 49 65 36 104 428 363 40 11 20 14 121
2024/20251.062 224 489 349 0 0 0 0 0 0 0 0 0
Totale 16.487